Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.
Guerrouahen BS, Futami M, Vaklavas C, Kanerva J, Whichard ZL, Nwawka K, Blanchard EG, Lee FY, Robinson LJ, Arceci R, Kornblau SM, Wieder E, Cayre YE, Corey SJ.
Guerrouahen BS, et al. Among authors: blanchard eg.
Clin Cancer Res. 2010 Feb 15;16(4):1149-58. doi: 10.1158/1078-0432.CCR-09-2416. Epub 2010 Feb 9.
Clin Cancer Res. 2010.
PMID: 20145167
Free PMC article.